We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$18B
AUM Growth
-$450M
(-2.4%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-6.64%
Top 10 Holdings %
Top 10 Hldgs %
34.95%
Holding
1,055
New
324
Increased
137
Reduced
183
Closed
377
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$489M |
| 2 |
Merck
MRK
|
+$271M |
| 3 |
JD.com
JD
|
+$243M |
| 4 |
Marathon Petroleum
MPC
|
+$214M |
| 5 |
Willis Towers Watson
WTW
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$232M |
| 2 |
Applied Materials
AMAT
|
+$220M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$195M |
| 4 |
Intel
INTC
|
+$174M |
| 5 |
ExxonMobil
XOM
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.28% |
| 2 | Consumer Discretionary | 6.72% |
| 3 | Financials | 3.73% |
| 4 | Technology | 3.37% |
| 5 | Materials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Teck Resources
TECK
$32.6B
| $9.02M | 0.05% |
391,359
-1,008,641
| -72% | -$22.9M |
|
227
PUT
MetLife
MET
$62.1B
| $8.98M | 0.05% |
150,000
| – | – |
|
|
HARP
228
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $8.75M | 0.05% |
63,057
+19,727
| +46% | +$3.76M |
|
229
Intellia Therapeutics
NTLA
$1.67B
| $8.74M | 0.05% |
+54,009
| New | +$4.21M |
|
230
CALL
Accenture
ACN
$108B
| $8.46M | 0.05% |
28,700
-19,000
| -40% | -$5.44M |
|
231
CALL
Cigna
CI
$74.6B
| $8.44M | 0.05% |
+35,600
| New | +$8.89M |
|
232
iShares China Large-Cap ETF
FXI
$4.31B
| $8.34M | 0.05% |
+180,000
| New | +$8.31M |
|
233
CALL
Nucor
NUE
$62.1B
| $8.31M | 0.05% |
+86,600
| New | +$8.1M |
|
234
Travere Therapeutics
TVTX
$5.78B
| $8.28M | 0.05% |
567,183
+304,170
| +116% | +$6M |
|
235
Linde
LIN
$226B
| $8.26M | 0.05% |
+28,577
| New | +$8.33M |
|
236
XPeng
XPEV
$11.6B
| $8.1M | 0.05% |
+182,281
| New | +$6.21M |
|
|
RACB
237
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $8M | 0.04% |
800,000
| – | – |
|
238
PUT
Amazon
AMZN
$2.96T
| $7.91M | 0.04% |
46,000
-474,000
| -91% | -$78.8M |
|
239
Vroom Inc
VRM
$48.2M
| $7.85M | 0.04% |
2,344
+2,076
| +775% | +$7.06M |
|
240
GH Research
GHRS
$2.08B
| $7.82M | 0.04% |
+360,000
| New | +$7.35M |
|
241
Mercado Libre
MELI
$92.3B
| $7.77M | 0.04% |
+4,989
| New | +$7.32M |
|
|
CMPS
242
Compass Pathways
CMPS
$1.83B
| $7.61M | 0.04% |
199,591
+129,591
| +185% | +$4.63M |
|
243
Jazz Pharmaceuticals
JAZZ
$16.7B
| $7.23M | 0.04% |
40,688
+35,088
| +627% | +$6.08M |
|
244
CALL
KLA
KLAC
$259B
| $7M | 0.04% |
+216,000
| New | +$6.92M |
|
245
CALL
NetEase
NTES
$84.7B
| $6.92M | 0.04% |
+60,000
| New | +$6.61M |
|
|
246
PUT
NetEase
NTES
$84.7B
| $6.92M | 0.04% |
+60,000
| New | +$6.61M |
|
247
CALL
Trade Desk
TTD
$6.49B
| $6.88M | 0.04% |
89,000
-21,000
| -19% | -$1.34M |
|
|
GAP
248
PUT
The Gap Inc
GAP
$7.37B
| $6.73M | 0.04% |
200,000
| – | – |
|
249
4D Molecular Therapeutics
FDMT
$562M
| $6.63M | 0.04% |
275,123
-1,171
| -0.4% | -$35.8K |
|
250
PUT
American Eagle Outfitters
AEO
$3.01B
| $6.57M | 0.04% |
+175,000
| New | +$6.06M |
|
Similar funds
AFM
GCP
LCM
MAP
MA
LFM
NSAM
ABI
Laurion Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Laurion Capital Management held 1,055 positions worth $18B, down 2.4% from $18.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Laurion Capital Management withdrew a net $1.2B in Q2 2021, closing 377 positions and reducing 183 holdings. Its most notable exit was Baidu, an estimated $232M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 9.3% of assets, up from 6.1% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Laurion Capital Management opened a new position in JD.com worth $257M.
- Laurion Capital Management's largest Q2 2021 buy was JD.com: 3,225,000 shares worth $257M.
- Laurion Capital Management added most to Alibaba in Q2 2021, an estimated $489M increase.
- Laurion Capital Management's biggest Q2 2021 reduction was Paramount Global Class B, cutting an estimated $195M.
- Laurion Capital Management fully exited Baidu in Q2 2021, selling an estimated $232M.
- Laurion Capital Management's ten largest holdings make up 35% of its $18B portfolio in Q2 2021.
- Laurion Capital Management opened 324 new positions and closed 377 in Q2 2021.
- Laurion Capital Management's portfolio value fell 2.4% quarter-over-quarter to $18B.
Based on Laurion Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.